SEC Info - Kendrick Charles Morgan Jr. - ‘4’ for 6/9/22 re: Elevance Health, Inc.

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Kendrick Charles Morgan JR

(Last)

(First)

(Middle)

220 VIRGINIA AVE

(Street)

INDIANAPOLIS

46204

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Anthem, Inc. [ ANTM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
EVP & President, Commercial

3. Date of Earliest Transaction (Month/Day/Year)
6/9/22

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	6/9/22		M		1,999	A	$307.68	16,528	D
Common Stock	6/9/22		M		2,774	A	$271.27	19,302	D
Common Stock	6/9/22		M		568	A	$232.04	19,870	D
Common Stock	6/9/22		M		987	A	$311.48	20,857	D
Common Stock	6/9/22		S		2,200	D	$487.45 ⁽¹⁾	18,657	D
Common Stock	6/9/22		S		2,616	D	$488.64 ⁽²⁾	16,041	D
Common Stock	6/9/22		S		784	D	$489.49 ⁽³⁾	15,257	D
Common Stock	6/9/22		S		522	D	$490.83 ⁽⁴⁾	14,735	D
Common Stock	6/9/22		S		206	D	$491.39	14,529	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (Right to Buy)	$307.68	6/9/22		M			1,999	⁽⁵⁾	3/1/29	Common Stock	1,999	$0	0	D
Employee Stock Option (Right to Buy)	$271.27	6/9/22		M			2,774	⁽⁶⁾	3/2/30	Common Stock	2,774	$0	1,387	D
Employee Stock Option (Right to Buy)	$232.04	6/9/22		M			568	⁽⁷⁾	3/1/28	Common Stock	568	$0	0	D
Employee Stock Option (Right to Buy)	$311.48	6/9/22		M			987	⁽⁸⁾	3/1/31	Common Stock	987	$0	1,976	D

Explanation of Responses:

(1) This transaction was executed in multiple trades at prices ranging from $487.13 to $487.89. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

(2) This transaction was executed in multiple trades at prices ranging from $488.19 to $489.18. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

(3) This transaction was executed in multiple trades at prices ranging from $489.19 to $489.83. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

(4) This transaction was executed in multiple trades at prices ranging from $490.37 to $491.33. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

(5) The option represents a right to purchase a total of 2,997 shares, and is exercisable in three annual installments, with one installment of 998 shares, one installment of 999 shares and one installment of 1,000 shares, beginning on 3/1/20, which is the one-year anniversary of the option grant date.

(6) The option represents a right to purchase a total of 4,161 shares, and is exercisable in three annual installments of 1,387 shares each, beginning on 3/2/21, which is the one-year anniversary of the option grant date.

(7) The option represents a right to purchase a total of 3,404 shares, and is exercisable in six semi-annual installments, with four installments of 567 shares each and two installments of 568 shares each beginning on 9/1/18, which is the six-month anniversary of the date on which the option was granted.

(8) The option represents a right to purchase a total of 2,963 shares, and is exercisable in three annual installments, with one installment of 987 shares and two installments of 988 shares each, beginning on 3/1/22, which is the one-year anniversary of the option grant date.

Remarks:

	/s/ Kathleen S. Kiefer, Attorney in fact	6/13/22
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

____________ Transaction Codes:
M	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
S	Open market or private sale of non-derivative or derivative security.

Kendrick Charles Morgan Jr. – ‘4’ for 6/9/22 re: Elevance Health, Inc.

On: Monday, 6/13/22, at 4:32pm ET · For: 6/9/22 · Accession #: 1156039-22-73 · File #: 1-16751

Previous ‘4’: ‘4’ on 3/3/22 for 3/1/22 · Next: ‘4’ on 11/3/22 for 11/1/22 · Latest: ‘4’ on 3/12/24 for 3/8/24

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34

Filing Table of Contents

This ‘4’ Document is an XML Data File that may be rendered in various formats:

Kendrick Charles Morgan Jr. – ‘4’ for 6/9/22 re: Elevance Health, Inc.

On: Monday, 6/13/22, at 4:32pm ET · For: 6/9/22 · Accession #: 1156039-22-73 · File #: 1-16751

Previous ‘4’: ‘4’ on 3/3/22 for 3/1/22 · Next: ‘4’ on 11/3/22 for 11/1/22 · Latest: ‘4’ on 3/12/24 for 3/8/24

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34Filing Table of Contents

This ‘4’ Document is an XML Data File that may be rendered in various formats:

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34

Filing Table of Contents